I) DTPa-HepB-IPV: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.2 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.
II) Hib: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, aluminium 0.12 mg ut aluminii phosphas, pro praeparatione.
I) et II) corresp. DTPa-HepB-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.32 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.
Packungsbestandteile
II
Injection suspension
Inactive agents
Dose
Aluminii Phosphas
Conjugata cum Toxoido Tetani
10 µg
Lactosum
Polysaccharida Haemophili Influenzae Typus B
20752
I
Injection suspension
Active Agent
Dose
Haemagglutininum Filamentosum (B. Pertussis)
25µg / 0.5ml
Hepatitidis b viri Antigenum Adnr
10µg / 0.5ml
Pertactinum (B. Pertussis)
8µg / 0.5ml
Toxoidum Diphtheriae
30U.I. / 0.5ml
Toxoidum Pertussis
25µg / 0.5ml
Toxoidum Tetani
40U.I. / 0.5ml
Virus Poliomyelitis Typus 1 Inactivatus (Mahoney)
40U.I. / 0.5ml
Virus Poliomyelitis Typus 2 Inactivatus (Mef1)
8U.I. / 0.5ml
Virus Poliomyelitis Typus 3 Inactivatus (Saukett)
32U.I. / 0.5ml
Inactive agents
Dose
Aluminii Hydroxidum Hydricum ad Adsorptionem
Aluminii Phosphas
Medium
199
Sodium Chloride
Source
Data was imported : 08.11.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
